Why the study?
Cirrhotic cardiomyopathy was neglected and historically confused with alcoholic cardiomyopathy, but its diagnosis has become increasingly important as a significant contributor to morbidity and mortality in cirrhotic patients.
Answers are grounded in this paper and cite their sources.
Cirrhotic cardiomyopathy is an important clinical entity contributing to morbidity and mortality in cirrhotic patients, requiring specific diagnostic and management strategies.
Cirrhotic cardiomyopathy historically has been confused as alcoholic cardiomyopathy. The key points for diagnosis of cirrhotic cardiomyopathy have been well explained, however this entity was neglected for a long time. Nowadays the diagnosis of this entity has become important because it is a factor that contributes significantly to morbidity-mortality in cirrhotic patients. Characteristics of cirrhotic cardiomyopathy are a hyperdynamic circulatory state, altered diastolic relaxation, impaired contractility, and electrophysiological abnormalities, particularity QT interval prolongation. The pathogenesis includes impaired function of beta-receptors, altered transmembrane currents and overproduction of cardiodepressant factors, such as nitric oxide, cytokines and endogenous cannabinoids. In addition to physical signs of hyperdynamic state and heart failure under stress conditions, the diagnosis can be done with dosage of serum markers, electrocardiography, echocardiography and magnetic resonance. The treatment is mainly supportive, but orthotopic liver transplantation appears to improve this condition although the prognosis of liver transplantation in patients with cirrhotic cardiomyopathy is uncertain.
No takes yet. Share an insight, caveat, or question.
Carvalho et al. (2019) conducted a review in Cirrhotic cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: